Indivior (LON:INDV) Trading Down 19.5% - Time to Sell?

Indivior PLC (LON:INDV - Get Free Report)'s share price fell 19.5% on Thursday . The company traded as low as GBX 640 ($8.09) and last traded at GBX 698.90 ($8.83). 1,716,748 shares were traded during trading, an increase of 144% from the average session volume of 704,709 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Ratings Changes

Separately, Jefferies Financial Group reiterated a "buy" rating and set a GBX 1,800 ($22.74) price target on shares of Indivior in a report on Tuesday, December 17th.

Indivior Stock Performance

The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The stock has a fifty day simple moving average of GBX 920.11 and a two-hundred day simple moving average of GBX 850.81. The stock has a market capitalization of £1.08 billion, a price-to-earnings ratio of -570.87, a P/E/G ratio of -5.57 and a beta of 0.19.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.